Clinical data | |
---|---|
Trade names | Trobicin |
AHFS/Drugs.com | Monograph |
Pregnancy category |
|
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
|
|
Synonyms | (2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)decahydro-4H-pyrano[2,3-b][1,4]benzodioxin-4-one |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.015.374 |
Chemical and physical data | |
Formula | C14H24N2O7 |
Molar mass | 332.35 g/mol |
3D model (Jmol) | |
|
|
|
|
(what is this?) |
Spectinomycin, sold under the tradename Trobicin among others, is an antibiotic useful for the treatment of gonorrhea infections. It is given by injection into a muscle.
Common side effects include pain at the area of injection, rash, nausea, fever, and trouble sleeping. Severe allergic reactions may occasionally occur. It is generally safe to use during pregnancy. It may be used by those who are allergic to penicillin or cephalosporins. It is in the aminocyclitol class of drugs and works by stopping the making of protein by certain bacteria.
Spectinomycin was discovered 1961. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is about US$5 per dose. It is not available in the United States. It is made from the bacterium Streptomyces spectabilis.
It is given by intramuscular injection to treat gonorrhea, especially in patients who are allergic to penicillins.
This antibiotic is no longer available in the United States.
Side effects include itching, chills, stomach ache, and red rash.
Spectinomycin binds to the 30S subunit of the bacterial ribosome and interrupts protein synthesis. One form of resistance has emerged in the 16S ribosomal RNA in .